MARKERS OF INFLAMMATION IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND CARDIOVASCULAR PATHOLOGY

MARKERS OF INFLAMMATION IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND CARDIOVASCULAR PATHOLOGY

Objective: to estimate the levels of high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), tumor necrosis factor-a (TNF-α), and soluble TNF-α receptor type 1 (sTNF-R1) in patients with antiphospholipid syndrome (APS) and their association with cardiovascular pathology. Subjects and meth...

Full description

Bibliographic Details
Main Authors:	Nataliya Valer'evna Seredavkina, T M Reshetnyak, E N Aleksandrova, A A Novikov, E S Mach, D S Novikova, M A Diatroptova, E L Nasonov, Nataliya Valeryevna Seredavkina
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2010-10-01
Series:	Научно-практическая ревматология
Subjects:	high-sensitivity c-reactive protein interleukin-6 tumor necrosis factor-a soluble tnf-α receptor type 1 antiphospholipid syndrome thrombosis atherosclerosis
Online Access:	https://rsp.mediar-press.net/rsp/article/view/866

Similar Items

Cytokines and neopterin in antiphospholipid syndrome
by: E N Alexandrova, et al.
Published: (2009-04-01)

C-reactive protein in antiphospholipid syndrome: relationship with cardiovascular pathology
by: N V Seredavkina, et al.
Published: (2009-08-01)

THE IX EUROPEAN FORUM ON ANTIPHOSPHOLIPID ANTIBODIES. A BRIEF REVIEW
by: Nataliya V Seredavkina, et al.
Published: (2014-03-01)

Antiphospholipid syndrome and exogenic factors ofthromboses risk
by: E S Mach, et al.
Published: (2004-11-01)

Thromboembolic complications in antiphospholipid syndrome and ankylosing spondylitis (two clinical cases)
by: K. S. Nurbaeva, et al.
Published: (2021-02-01)

Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome
by: T M Reshetniak, et al.
Published: (2013-01-01)

THE LEVELS OF PLASMINOGEN AND INHIBITOR OF PLASMINOGEN ACTIVATORS OF TYPE 1 IN ANTIPHOSPHOLIPID SYNDROME
by: E V Ostryakova, et al.
Published: (2012-05-01)

Direct-acting oral anticoagulants in antiphospholipid syndrome
by: T. M. Reshetnyak, et al.
Published: (2021-01-01)

Effectiveness and safety of selective and non - selective factor Xa inhibitors in antiphospholipid syndrome and systemic lupus erythematosus: anti - Xa - activity range
by: N V Seredavkina, et al.
Published: (2019-05-01)

Recurrences of thromboses and hemorrhagic complications in patients with antiphospholipid syndrome during therapy with warfarin plus aspirin
by: Lyubov' Valer'evna Kondrat'eva, et al.
Published: (2010-05-01)

Blood nitrates content in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: D V Reshetnyak, et al.
Published: (2004-05-01)

Gastrointestinal symptoms as the first manifestation of antiphospholipid syndrome
by: Xiaojuan Zou, et al.
Published: (2021-04-01)

PREVENTION OF THROMBOSES IN ANTIPHOSPHOLIPID SYNDROME
by: Lyubov Valeryevna Kondratyeva, et al.
Published: (2009-09-01)

Von Willebrand factor antigen in systemic lupus erythematosus and antiphospholipid syndrome
by: A A Novikov, et al.
Published: (2004-08-01)

Efficacy and tolerance of selective and non-selective factor Xa inhibitors in the prevention of thrombosis in kidney disease in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: N. V. Seredavkina, et al.
Published: (2019-03-01)

RECURRENT FETAL LOSS IN THE PRIMARY ANTIPHOSPHOLIPID SYNDROME (CASE REPORT)
by: Z S Alekberova, et al.
Published: (2000-02-01)

Clinical features and diagnosis of Ph - negative myeloproliferative neoplasms occurring in conjunction with the antiphospholipid syndrome
by: A L Melikyan, et al.
Published: (2019-07-01)

Mental disorders and cognitive impairment in patients with antiphospholipid syndrome
by: A. B. Borisova, et al.
Published: (2020-06-01)

ANTIPHOSPHOLIPID SYNDROME: DIAGNOSIS AND CLINICAL MANIFESTATIONS (A LECTURE)
by: Tat’yana M Reshetnyak
Published: (2014-03-01)

Current approaches to prevention and treatment of antiphospholipid syndrome
by: E L Nasonov
Published: (2003-05-01)

Immunological markers of antiphospholipid syndrome. Part I – antiphospholipid antibodies
by: E N Alexandrova, et al.
Published: (2009-10-01)

The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus
by: M. Taraborelli, et al.
Published: (2016-12-01)

NEW ORAL ANTICOAGULANTS IN THE THERAPY OF ANTIPHOSPHOLIPID SYNDROME
by: M. A. Satybaldyeva, et al.
Published: (2016-07-01)

LUNGS IN ANTIPHOSPHOLIPID SYNDROME – THREE CASE REPORTS
by: Zlata Remškar
Published: (2001-05-01)

Atherosclerotic vessel damage in systemic lupus erythematosus and antiphospholipid syndrome in men
by: A. I. Iljina, et al.
Published: (2005-10-01)

Update on antiphospholipid antibody syndrome
by: Michelle Remião Ugolini Lopes, et al.

Risk factors for venous thromboses in patients with rheumatoid arthritis
by: M. A. Satybaldyeva, et al.
Published: (2019-01-01)

On the pathogenesis of thromboses in antiphospholipid syndrome
by: T. A. Sukontseva, et al.
Published: (2018-11-01)

Lung Pathology in Antiphospholipid Syndrome
by: T. M. Reshetnyak, et al.
Published: (2005-10-01)

Role of cytokines in the pathogenesis of rheumatoid arthritis
by: Aleksandr Aleksandrovich Novikov, et al.
Published: (2010-04-01)

Clinical and immunological features of primary and secondary antiphospholipid syndrome
by: T M Reshetnvak, et al.
Published: (2004-08-01)

STUDIES DEVOTED TO ANTIPHOSPHOLIPID SYNDROME AT THE V.A. NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY: MAIN ACHIEVEMENTS (ON THE OCCASION OF THE 40th ANNIVERSARY OF THE DISSERTATION BOARD)
by: T. M. Reshetnyak
Published: (2017-01-01)

Mechanisms of Endothelial Dysfunction in Antiphospholipid Syndrome: Association With Clinical Manifestations
by: Manuela Velásquez, et al.
Published: (2018-12-01)

Antiphospholipid Syndrome Novel Therapies
by: Mohamad Bittar, et al.
Published: (2014-07-01)

Risk factors for venous thromboembolic events in patients with rheumatoid arthritis
by: M. A. Satybaldyeva, et al.
Published: (2016-10-01)

VWF, Platelets and the Antiphospholipid Syndrome
by: Shengshi Huang, et al.
Published: (2021-04-01)

Low levels of vitamin D are common in primary antiphospholipid syndrome with thrombotic disease
by: P.L. Meroni, et al.
Published: (2012-12-01)

The Weight of IgA Anti-β2glycoprotein I in the Antiphospholipid Syndrome Pathogenesis: Closing the Gap of Seronegative Antiphospholipid Syndrome
by: Oscar Cabrera-Marante, et al.
Published: (2020-11-01)

Clinical case of rheumatoid arthritis with antiphospholipid antibody syndrome
by: G. G Arabidze, et al.
Published: (2015-09-01)

Antiphospholipid Antibodies and Infection: Non Nova Sed Nove
by: Savino Sciascia, et al.
Published: (2021-06-01)